Artwork

Content provided by Audioboom and RCGP eLearning Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and RCGP eLearning Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

Respiratory syncytial virus (RSV)

10:02
 
Distribuie
 

Manage episode 436655401 series 2631159
Content provided by Audioboom and RCGP eLearning Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and RCGP eLearning Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Sponsored by Pfizer Limited. Pfizer has had no involvement in the editorial component of this educational material. Editorial and content decisions were made solely by the RCGP.
Respiratory syncytial virus (RSV) is an RNA virus which causes respiratory infections; the most significant clinical effects are in infants and people who are elderly and have chronic medical conditions or immunosuppression. In this podcast, Professor Simon de Lusignan from the RCGP’s Research and Surveillance Centre discusses the new RSV vaccination programme, which offers a one-off vaccine to everyone at the age of 75, with an initial catch-up programme between the ages of 75 and 80. He also touches on monoclonal antibodies and antivirals, which are given in secondary care to children who are at high risk of serious complications if they contract RSV.
  continue reading

127 episoade

Artwork
iconDistribuie
 
Manage episode 436655401 series 2631159
Content provided by Audioboom and RCGP eLearning Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and RCGP eLearning Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Sponsored by Pfizer Limited. Pfizer has had no involvement in the editorial component of this educational material. Editorial and content decisions were made solely by the RCGP.
Respiratory syncytial virus (RSV) is an RNA virus which causes respiratory infections; the most significant clinical effects are in infants and people who are elderly and have chronic medical conditions or immunosuppression. In this podcast, Professor Simon de Lusignan from the RCGP’s Research and Surveillance Centre discusses the new RSV vaccination programme, which offers a one-off vaccine to everyone at the age of 75, with an initial catch-up programme between the ages of 75 and 80. He also touches on monoclonal antibodies and antivirals, which are given in secondary care to children who are at high risk of serious complications if they contract RSV.
  continue reading

127 episoade

Toate episoadele

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință